INTS vs GILD: Which Stock is Better?
Side-by-side comparison of Intensity Therapeutics Inc and Gilead Sciences Inc in 2026
INTS
Intensity Therapeutics Inc
$5.50
GILD
Gilead Sciences Inc
$139.03
Key Metrics Comparison
| Metric | INTS | GILD | Winner |
|---|---|---|---|
| Market Cap | $13.87M | $172.51B | GILD |
| P/E Ratio | N/A | 20.50 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | 0.0% | 0.0% | GILD |
| Gross Margin | 0.0% | 78.8% | GILD |
Analyze INTS
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is INTS or GILD a better investment?
Comparing INTS and GILD: Intensity Therapeutics Inc has a market cap of $13.87M while Gilead Sciences Inc has $172.51B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between INTS and GILD?
INTS (Intensity Therapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: INTS or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: INTS or GILD?
GILD has higher revenue growth at 0.0% vs 0.0% for INTS.
Which company is more profitable: INTS or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 0.0% for INTS.
Which is the larger company: INTS or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $172.51B compared to $13.87M for INTS.
Should I buy INTS or GILD in 2026?
Both INTS and GILD have investment merit. INTS trades at $5.50 while GILD trades at $139.03. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between INTS and GILD stock?
Key differences: Market Cap ($13.87M vs $172.51B), P/E Ratio (N/A vs 20.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 78.8%).